China Biotech
China Pharma Pulse: Innovation, Reform & Global Dealmaking Surge
Outbound licensing surges as China’s biotech sector hits its stride. Key deals, IPOs, IND reform, GLP-1 momentum, and TCE/autoimmune advances.
China Biotech
Outbound licensing surges as China’s biotech sector hits its stride. Key deals, IPOs, IND reform, GLP-1 momentum, and TCE/autoimmune advances.
XtalPi
XtalPi teams up with DoveTree in a $6 billion AI-powered drug discovery partnership to develop new small molecules and antibodies across major disease areas.
Biotech Deals
Madrigal Pharmaceuticals has partnered with China’s CSPC in a $2B deal for SYH2086, an oral GLP-1 candidate for MASH and metabolic disease.